Cargando…

Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin

Heparin is a centennial anticoagulant drug broadly employed for treatment and prophylaxis of thromboembolic conditions. Although unfractionated heparin (UFH) has already been shown to have remarkable pharmacological potential for treating a variety of diseases unrelated with thromboembolism, includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Roberto P., Tovar, Ana M.F., Oliveira, Marcos R., Piquet, Adriana A., Capillé, Nina V., Oliveira, Stephan N.M.C.G., Correia, Ana H., Farias, José N., Vilanova, Eduardo, Mourão, Paulo A.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135479/ https://www.ncbi.nlm.nih.gov/pubmed/35707626 http://dx.doi.org/10.1055/a-1750-1300

Ejemplares similares

Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
por: Oliveira, Stephan N.M.C.G., et al.
Publicado: (2022)

Approaches to Assure Similarity between Pharmaceutical Heparins from Two Different Manufacturers
por: Bezerra, Francisco Felipe, et al.
Publicado: (2023)

Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia
por: Vilanova, Eduardo, et al.
Publicado: (2019)

Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs
por: Tovar, Ana M. F., et al.
Publicado: (2016)

Bovine and porcine heparins: different drugs with similar effects on human haemodialysis
por: Tovar, Ana MF, et al.
Publicado: (2013)

Reversal of the anticoagulant and anti-hemostatic effect of low molecular weight heparin by direct prothrombin activation
por: Andrade, S.A., et al.
Publicado: (2012)

Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine
por: Santos, Gustavo R.C., et al.
Publicado: (2017)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

Comparison Between K(3)EDTA and Lithium Heparin as Anticoagulant to Isolate Bovine Granulocytes From Blood
por: Baien, Shima Hassan, et al.
Publicado: (2018)

Anticoagulants and the Hemostatic System: A Primer for Occupational Stress Researchers
por: Arble, Eamonn, et al.
Publicado: (2021)

Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016)

Non-Anticoagulant Heparins as Heparanase Inhibitors
por: Cassinelli, Giuseppe, et al.
Publicado: (2020)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
por: Braz-de-Melo, Heloísa Antoniella, et al.
Publicado: (2021)

Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation
por: Montalvá, Eva, et al.
Publicado: (2022)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Heparin and Related Drugs: Beyond Anticoagulant Activity
por: Page, Clive
Publicado: (2013)

Not Just Anticoagulation—New and Old Applications of Heparin
por: Zang, Lixuan, et al.
Publicado: (2022)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood
por: Hogwood, John, et al.
Publicado: (2020)

Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs
por: Kulkarni, Preeti, et al.
Publicado: (2016)

Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022)

Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
por: Winzely, Maximilian, et al.
Publicado: (2021)

Preparation, Anticoagulant and Antioxidant Properties of Glucosamine-Heparin Salt
por: Miao, Qin, et al.
Publicado: (2022)

Non-anticoagulant heparin derivatives for COVID-19 treatment
por: Cao, Min, et al.
Publicado: (2023)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023)

Hemostatic Resuscitation
por: McMullin, N. R., et al.
Publicado: (2006)

Hemostatic Resuscitation
por: McMullin, N. R., et al.
Publicado: (2006)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Publicado: (2021)

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Publicado: (2021)

Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia
por: Nilius, Henning, et al.
Publicado: (2021)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9sb4rd6k7rqldbogcdo2hnhgs